Significant reduction of antibiotic use in the community after a nationwide campaign in France, PLoS Med, vol.6, pp.2002-2009, 2002. ,
URL : https://hal.archives-ouvertes.fr/inserm-00700534
Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology, Diagnostic Microbiology and Infectious Disease, vol.65, issue.1, pp.49-57, 2009. ,
DOI : 10.1016/j.diagmicrobio.2009.05.009
URL : https://hal.archives-ouvertes.fr/inserm-00533125
Infant pneumococcal vaccination on invasive pneumococcal diseases in France, Euro Surveill, vol.13, pp.367-72, 2001. ,
Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis, Scientific Reports, vol.25, p.11293, 2015. ,
DOI : 10.1038/srep11293
Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany, PLOS ONE, vol.9, issue.6, p.131494, 2015. ,
DOI : 10.1371/journal.pone.0131494.s002
Serotype epidemiology of invasive pneumococcal disease in Swiss adults: A nationwide population-based study, Vaccine, vol.32, issue.40, pp.5185-91, 2014. ,
DOI : 10.1016/j.vaccine.2014.07.060
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study, The Lancet Infectious Diseases, vol.11, issue.10, pp.760-768, 2011. ,
DOI : 10.1016/S1473-3099(11)70090-1
Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain, Clinical Microbiology and Infection, vol.15, issue.11, pp.1013-1022, 2009. ,
DOI : 10.1111/j.1469-0691.2009.02904.x
Effect of introduction of the pneumococcal conjugate vaccine on drugresistant Streptococcus pneumoniae, N Engl J Med, vol.14, pp.1455-63, 2006. ,
Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites, PLoS Medicine, vol.18, issue.9, p.1001517, 2013. ,
DOI : 10.1371/journal.pmed.1001517.s022
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine, The Journal of Infectious Diseases, vol.201, issue.1, pp.32-41, 2010. ,
DOI : 10.1086/648593
Decline in Invasive Pneumococcal Disease after the Introduction of Protein???Polysaccharide Conjugate Vaccine, New England Journal of Medicine, vol.348, issue.18, pp.1737-1783, 2009. ,
DOI : 10.1056/NEJMoa022823
Clinical and Serologic Response to the 23-valent Polysaccharide Pneumococcal Vaccine in Children and Teens with Recurrent Upper Respiratory Tract Infections and Selective Antibody Deficiency, The Pediatric Infectious Disease Journal, vol.35, issue.2, pp.205-213, 2016. ,
DOI : 10.1097/INF.0000000000000964
New conjugate vaccines for the prevention of pneumococcal disease in developing countries, Drugs of Today, vol.47, issue.3, pp.207-221, 2011. ,
DOI : 10.1358/dot.2011.47.3.1556471
Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001???2012, Vaccine, vol.33, issue.2, pp.359-66, 2001. ,
DOI : 10.1016/j.vaccine.2014.11.011
in Ferrets, The Journal of Infectious Diseases, vol.202, issue.8, pp.1287-95, 2010. ,
DOI : 10.1086/656333
Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models, Proceedings of the Royal Society B: Biological Sciences, vol.16, issue.2, p.20130519, 2013. ,
DOI : 10.3851/IMP1730
Did Media Attention of the 2009 A(H1N1) Influenza Epidemic Increase Outpatient Antibiotic Use in France?: A Time-Series Analysis, PLoS ONE, vol.55, issue.7, p.69075, 2013. ,
DOI : 10.1371/journal.pone.0069075.s003
SUMMARY, Epidemiology and Infection, vol.144, issue.03, pp.607-618, 2016. ,
DOI : 10.1016/S1473-3099(04)00938-7
Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine, JAMA, vol.294, issue.16, pp.2043-51, 2005. ,
DOI : 10.1001/jama.294.16.2043
Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, New England Journal of Medicine, vol.360, issue.3, pp.244-56, 2009. ,
DOI : 10.1056/NEJMoa0800836
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance, The Lancet Infectious Diseases, vol.15, issue.3, pp.301-310, 2015. ,
DOI : 10.1016/S1473-3099(14)71081-3
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway, Vaccine, vol.31, issue.52, pp.6232-6240, 2013. ,
DOI : 10.1016/j.vaccine.2013.10.032
Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality, Clinical Infectious Diseases, vol.59, issue.8, pp.1066-73, 2014. ,
DOI : 10.1093/cid/ciu524
Outpatient Antibiotic Use in France between 2000 and 2010: after the Nationwide Campaign, It Is Time To Focus on the Elderly, Antimicrobial Agents and Chemotherapy, vol.58, issue.1, pp.71-78, 2014. ,
DOI : 10.1128/AAC.01813-13
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children, Clinical Infectious Diseases, vol.61, issue.5, pp.767-75, 2015. ,
DOI : 10.1093/cid/civ368
Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development, Vaccine, vol.28, issue.26, pp.4249-59, 2010. ,
DOI : 10.1016/j.vaccine.2010.04.020
Pneumococcal Meningitis Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France, The Pediatric Infectious Disease Journal, vol.34, issue.10, pp.260-263, 2015. ,
DOI : 10.1097/INF.0000000000000818
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine, PEDIATRICS, vol.125, issue.5, pp.866-75, 2010. ,
DOI : 10.1542/peds.2009-1405
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study, The Lancet Infectious Diseases, vol.15, issue.5, pp.535-578, 2015. ,
DOI : 10.1016/S1473-3099(15)70044-7
Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001???2013, Vaccine, vol.32, issue.22, pp.2553-62, 2001. ,
DOI : 10.1016/j.vaccine.2014.03.054
Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine, European Journal of Clinical Microbiology & Infectious Diseases, vol.14, issue.12, pp.1511-1520, 2011. ,
DOI : 10.1007/s10096-011-1251-9
Trends of Pneumococcal Meningitis in Children After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France, The Pediatric Infectious Disease Journal, vol.33, issue.12, pp.1216-1237, 2014. ,
DOI : 10.1097/INF.0000000000000451
Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan, Epidemiology and Infection, vol.57, issue.01, pp.61-69, 2010. ,
DOI : 10.1016/0378-1119(86)90215-5
Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing, Infection, Genetics and Evolution, vol.11, issue.8, pp.1929-1968, 2011. ,
DOI : 10.1016/j.meegid.2011.08.016
Outbreak of Invasive Streptococcus pneumoniae Serotype 12F Among a Marginalized Inner-City Population in Winnipeg, Canada, 2009-2011, Clinical Infectious Diseases, vol.59, issue.5, pp.651-658, 2009. ,
DOI : 10.1093/cid/ciu366
Molecular epidemiology of pneumococci obtained from Gambian children aged 2???29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine, BMC Infectious Diseases, vol.5, issue.1, p.81, 2008. ,
DOI : 10.1111/j.1365-2958.1991.tb02155.x
Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children, Vaccine, vol.33, issue.46, pp.6178-85, 2015. ,
DOI : 10.1016/j.vaccine.2015.10.015
Pneumococcal serotype evolution in Western Europe, BMC Infectious Diseases, vol.34, issue.4, p.419, 2015. ,
DOI : 10.1186/s12879-015-1147-x
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A, Vaccine, vol.29, issue.41, pp.7207-7218, 2011. ,
DOI : 10.1016/j.vaccine.2011.06.056
Clonal Expansion of the Macrolide Resistant ST386 within Pneumococcal Serotype 6C in France, PLoS ONE, vol.57, issue.3, p.90935, 2014. ,
DOI : 10.1371/journal.pone.0090935.t005
Estimating Rates of Carriage Acquisition and Clearance and Competitive Ability for Pneumococcal Serotypes in Kenya With a Markov Transition Model, Epidemiology, vol.23, issue.4, pp.510-519, 2013. ,
DOI : 10.1097/EDE.0b013e31824f2f32
Temporal Trends in Invasive Pneumococcal Disease and Pneumococcal Serotypes over 7 Decades, Clinical Infectious Diseases, vol.50, issue.3, pp.329-366, 2010. ,
DOI : 10.1086/649872
URL : http://cid.oxfordjournals.org/cgi/content/short/50/3/329
The Fitness Cost of Antibiotic Resistance in Streptococcus pneumoniae: Insight from the Field, PLoS ONE, vol.49, issue.10, p.29407, 2012. ,
DOI : 10.1371/journal.pone.0029407.s001